Johnson & Johnson: all 3,718 studies
Page 33 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.
- Harmonic™ vs. Electrocautery in AbdominoplastiesCompletedNCT00506740Not applicable
- Uterine Artery Occlusion for Fibroid Related BleedingTerminatedNCT00496067Not applicable
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.CompletedNCT00495118Phase 3
- A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusCompletedNCT00492661Phase 4
- The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With SchizophreniaTerminatedNCT00488891
- TVT-SECUR A Pilot Study for the Treatment of Stress Urinary IncontinenceCompletedNCT00463554
- Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)CompletedNCT00460720
- An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaCompletedNCT00460512Phase 3
- A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis PigmentosaTerminatedNCT00458575Phase 1
- RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical PracticeCompletedNCT00458367
- Uretal Flow Assessment During Gynecological ProceduresCompletedNCT00453882Not applicable
- TVT Worldwide RegistryCompletedNCT00453739
- Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial HypertensionWithdrawnNCT00453414Phase 2
- Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility StudyWithdrawnNCT00449085Phase 2
- A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)WithdrawnNCT00446602Phase 2
- The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) DiseaseCompletedNCT00446576Phase 3
- An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.CompletedNCT00440817
- VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the NetherlandsCompletedNCT00440765
- Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)TerminatedNCT00440674Phase 4
- Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple MyelomaCompletedNCT00440635
- ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.CompletedNCT00440479
- An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple MyelomaCompletedNCT00431769Phase 2
- Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00425321Phase 2
- A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With NarcolepsyCompletedNCT00424931Phase 2
- SEMPERFLO* Pain Management System in Inguinal Hernia RepairTerminatedNCT00423241Not applicable
- CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System EvaluationCompletedNCT00422435Phase 3
- A Study of Bortezomib as Consolidation Therapy in Patients With Multiple MyelomaCompletedNCT00416273Phase 3
- Consolidation Therapy With Bortezomib in Elderly Patients With Multiple MyelomaCompletedNCT00416208Phase 3
- A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaCompletedNCT00416169Phase 2
- Multi-Center Clinical Trial: Evaluation of Effectiveness and SafetyTerminatedNCT00415961Not applicable
- TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected PatientsCompletedNCT00412646Phase 2
- A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's DiseaseCompletedNCT00412321Phase 1
- A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative PainCompletedNCT00411307Phase 2
- Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back PainCompletedNCT00411268Phase 3
- A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With OsteoarthritisCompletedNCT00411164Phase 3
- A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer PainCompletedNCT00411034Phase 3
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic PainCompletedNCT00410943Phase 3
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic PainCompletedNCT00410878Phase 1
- Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer PainCompletedNCT00410787Phase 3
- Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)CompletedNCT00410748Phase 3
- A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant PainCompletedNCT00410644Phase 3
- A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.CompletedNCT00410540Phase 3
- An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT00402181Phase 2
- A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00401765Phase 1
- Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.CompletedNCT00399646Phase 2
- PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersCompletedNCT00399334
- An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mgCompletedNCT00399295Phase 1
- An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)CompletedNCT00399048Phase 3
- An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mgCompletedNCT00398957Phase 1
- A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back PainCompletedNCT00398788Phase 2
- Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)CompletedNCT00398749
- Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque PsoriasisCompletedNCT00396422Phase 2
- Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney FailureCompletedNCT00391287
- PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyCompletedNCT00388336Phase 2
- A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00380796
- A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking PantoprazoleCompletedNCT00378287Phase 1
- APART Advanced Profiling of Anti-Rheumatic TherapiesCompletedNCT00378261Phase 4
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
- Efficacy and Safety of Sinutab on Subjects in the Setting of a Common ColdCompletedNCT00378144Phase 4
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCompletedNCT00378092Phase 4
- A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth ControlCompletedNCT00377988
- REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease ManagementCompletedNCT00370214
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisCompletedNCT00369239Phase 4
- Registry for Acute Decompensated Heart Failure PatientsCompletedNCT00366639
- A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic PainCompletedNCT00364546Phase 3
- Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.CompletedNCT00364455Phase 3
- Longitudinal Registry for Advanced Heart Failure PatientsCompletedNCT00364416
- Registry for Acute Decompensated Heart Failure Patients Admitted to the ERCompletedNCT00364325
- A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.CompletedNCT00364260Phase 3
- A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.CompletedNCT00364247Phase 3
- A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement SurgeryCompletedNCT00361582Phase 3
- A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET StudyTerminatedNCT00360087Phase 3
- Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With SchizophreniaCompletedNCT00358852
- A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and AdolescentsCompletedNCT00355524Phase 2
- The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral DrugsApproved for marketingNCT00354627
- A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.CompletedNCT00354146Phase 2
- A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of SchizophreniaCompletedNCT00350467Phase 3
- Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00344422Phase 3
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended RegimenCompletedNCT00344383Phase 2
- A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.CompletedNCT00341055Phase 3
- An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.CompletedNCT00338624Phase 3
- An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three WeeksCompletedNCT00338416Phase 2
- Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced AnemiaCompletedNCT00338299Phase 2
- Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00338117Phase 3
- EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal FailureCompletedNCT00338000Phase 4
- An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four WeeksCompletedNCT00337948Phase 2
- Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With SchizophreniaCompletedNCT00334126Phase 3
- Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)CompletedNCT00333853Not applicable
- Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart AttacksCompletedNCT00331071
- A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326391Phase 3
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00326300Phase 3
- Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)TerminatedNCT00322543Phase 3
- An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional RegimenCompletedNCT00320580Phase 2
- The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia NervosaCompletedNCT00320567Phase 2
- Bosentan in Children With Pulmonary Arterial HypertensionCompletedNCT00319267Phase 3
- Open-label Study With Bosentan in Interstitial Lung DiseaseCompletedNCT00319033Phase 2/3
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
- Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyCompletedNCT00317486Phase 4
- Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary HypertensionCompletedNCT00313222Phase 3
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)TerminatedNCT00313196Phase 3